Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II, Open-Label, Single-Arm Trial Using KEYTRUDA (Pembrolizumab) as Initial Systemic Therapy in the Treatment of Advanced Mycosis Fungoides

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03695471
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:23.727868+00:00
Published At
2025-08-11T00:00:00+00:00
Record Updated At
2025-08-29
Results Posted At
2025-08-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Mycosis Fungoides", "Sezary Syndrome", "Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8", "Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8", "Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8", "Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8", "Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8", "Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8", "Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8", "Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8", "Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8", "Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8", "Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-08-29"
protocolSection.identificationModule.nctId
"NCT03695471"
protocolSection.identificationModule.officialTitle
"A Phase II, Open-Label, Single-Arm Trial Using KEYTRUDA (Pembrolizumab) as Initial Systemic Therapy in the Treatment of Advanced Mycosis Fungoides"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-08-11"

Study condition terms

  • Mycosis Fungoides (protocolSection.conditionsModule.conditions)
  • Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.